Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Grown Rogue InternationalGRUSF -2.22%43 PB Ratio is 6.52 as of Jul. 18, 2026, which is 37% above its 10-year median of 4.75. GuruFocus rates GRUSF with a GF Score™ of 43/100 and a GF Value™ of $0.44 (Fairly Valued). The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, Grown Rogue International ranks worse than 88.39% on this metric.
Grown Rogue International Inc stock PB Ratio (=6.74) is close to 1-year high of 7.28.
The historical rank and industry rank for Grown Rogue International's PB Ratio or its related term are showing as below:
GRUSF'
s PB Ratio Range Over the Past 10 Years
Min: 1.88 Med: 4.75 Max: 16.49
Current: 6.74
During the past 13 years, Grown Rogue International's highest PB Ratio was 16.49. The lowest was 1.88. And the median was 4.75.
GRUSF's PB Ratio is ranked worse than 88.39% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.91
vs GRUSF: 6.74
During the past 12 months, Grown Rogue International's average Book Value Per Share Growth Rate was -23.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 27.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Grown Rogue International was 78.90% per year. The lowest was -74.60% per year. And the median was 57.20% per year.
Back to Basics: PB Ratio
Grown Rogue International (OTCPK:GRUSF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Grown Rogue International PB Ratio Related Terms
Grown Rogue International PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grown Rogue International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grown Rogue International PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grown Rogue International's PB Ratio distribution charts can be found below:
* The bar in red indicates where Grown Rogue International's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Grown Rogue International (GRUSF) has a PB Ratio of 6.52 as of Jul. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Grown Rogue International and its competitors. This is 37% above median its historical median of 4.75. Over the past decade, Grown Rogue International's PB Ratio has ranged from 1.88 to 16.49. According to the industry distribution chart, Grown Rogue International ranks #815 out of 922 companies in the Drug Manufacturers industry, placing it in the top 88.4%.
Is Grown Rogue International's PB Ratio too high?
Grown Rogue International's current PB Ratio of 6.52 is 37% above median its 10-year median of 4.75. Over the past 10 years, this metric has ranged from a low of 1.88 to a high of 16.49. The Drug Manufacturers industry median PB Ratio is 1.91. Grown Rogue International's value of 6.52 is 241.4% above this industry median. Based on the distribution chart, Grown Rogue International ranks #815 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Grown Rogue International has a GF Score™ of 43/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Grown Rogue International's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grown Rogue International ranks #815 out of 922 companies for PB Ratio. This places Grown Rogue International in the lower half of its industry. The industry median PB Ratio is 1.91. Grown Rogue International's value of 6.52 is 241.4% above this benchmark. Historically, Grown Rogue International's own PB Ratio has ranged from 1.88 to 16.49 over the past decade. While the company's 10-year median is 4.75 vs. the industry median of 1.91, Grown Rogue International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.91, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grown Rogue International's current PB Ratio of 6.52 is 241.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Grown Rogue International and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grown Rogue International's current PB Ratio is 6.52, which is 37% above median its own 10-year median of 4.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grown Rogue International stock overvalued right now?
Based on GuruFocus' analysis, Grown Rogue International (GRUSF) is currently considered Fairly Valued. The stock's GF Value™ is $0.44, compared to a current price of $0.44 — trading 0.7% below its estimated fair value. The current PB Ratio is 6.52, which is 37% above median its 10-year median of 4.75 and 241.4% above the Drug Manufacturers industry median of 1.91. Grown Rogue International's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Grown Rogue International (GRUSF), the current PB Ratio is 6.52 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grown Rogue International (GRUSF) Overvalued in 2026?
Based on GuruFocus' analysis, Grown Rogue International stock appears to be undervalued.
The current stock price of $0.44 is trading 0.7% below its estimated GF Value™ of $0.44.
GuruFocus considers Grown Rogue International to be Fairly Valued.
Key valuation signals for GRUSF:
PB Ratio: 6.52 (37% above median its 10-year median of 4.75)
GF Value™: $0.44 vs. price of $0.44 (0.7% below fair value)
Industry Position: 241.4% above the Drug Manufacturers median (#815 of 922)
No single metric tells the full story. See the GRUSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grown Rogue International Inc is engaged in the business of growing and selling cannabis products. Its primary cannabis product produced and sold is cannabis flower. Geographically, the company generates a majority of its revenue from the United States. The company has identified three operating segments: the Oregon segment represents cannabis production and sales activities in Oregon; the Michigan segment represents cannabis production and sales activities in Michigan; and the New Jersey segment represents cannabis production and sales activities in New Jersey.
43GF Score
Get the complete analysis for GRUSF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRUSF has been successfully added to your 
